"Mesothelioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
| Descriptor ID |
D008654
|
| MeSH Number(s) |
C04.557.470.035.510 C04.557.470.660.510
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mesothelioma".
Below are MeSH descriptors whose meaning is more specific than "Mesothelioma".
This graph shows the total number of publications written about "Mesothelioma" by people in this website by year, and whether "Mesothelioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mesothelioma" by people in Profiles.
-
Commentary: Biphasic malignant mesothelioma-Survival of the fittest. J Thorac Cardiovasc Surg. 2020 04; 159(4):1596-1597.
-
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight. 2017 03 09; 2(5):e90772.
-
Peritoneal Deciduoid Mesothelioma: An Unusual Presentation Complicating an Already Challenging Diagnosis. Int J Surg Pathol. 2017 Jun; 25(4):352-356.
-
Disease mapping of zero-excessive mesothelioma data in Flanders. Ann Epidemiol. 2017 Jan; 27(1):59-66.e3.
-
A review and critique of U.S. EPA's risk assessments for asbestos. Crit Rev Toxicol. 2014 Jul; 44(6):499-522.
-
Abrogating G2/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma. Cancer Biol Ther. 2014 Apr; 15(4):380-8.
-
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res. 2010 Nov 15; 70(22):9053-61.
-
Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C. Ann Surg Oncol. 2011 Jan; 18(1):174-80.
-
Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. Cancer Biol Ther. 2009 Dec; 8(24):2406-16.
-
Mesothelioma - "not just in the chest". Ulster Med J. 2008 May; 77(2):133-4.